Johnson & Johnson/Tibotec (Public Company; JNJ; Pharmaceuticals industry): Senior Director Toxicology & Drug Development, (2005-Present) Preclinical Development Leader of rilpivirine (hiv-nnrti), telaprevir (hcv-pi), and rsv projects.
Co-chair Johnson & Johnson Precl...
Linkedin